NAYAB: A Randomised Double-Blind Placebo-Controlled Trial of Minocycline and/or Omega-3 Fatty Acids Added to Treatment as Usual for At Risk Mental States

被引:0
|
作者
Husain, Muhammad [1 ]
Chaudhry, Imran [1 ]
Deakin, Bill [1 ]
Husain, Nusrat [1 ]
Qurashi, Inti [1 ]
机构
[1] Univ Toronto, Ctr Addict & Mental Hlth, Toronto, ON, Canada
关键词
Early Intervention; Psychosis-Risk; Minocycline; Omega-3; Psychosis;
D O I
暂无
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
P552
引用
收藏
页码:384 / 385
页数:2
相关论文
共 50 条
  • [1] A randomised double-blind placebo-controlled trial of minocycline and/or omega-3 fatty acids added to treatment as usual for at risk Mental States: The NAYAB study
    Qurashi, Inti
    Chaudhry, Imran B.
    Khoso, Ameer B.
    Husain, Muhammad Omair
    Hafeez, Danish
    Kiran, Tayyeba
    Lane, Steven
    Naqvi, Haider A.
    Minhas, Fareed A.
    Nizami, Asad Tamizuddin
    Razzaque, Bushra
    Bokhari, Sumira Qambar
    Yung, Alison R.
    Deakin, Bill
    Husain, Nusrat
    BRAIN BEHAVIOR AND IMMUNITY, 2024, 115 : 609 - 616
  • [2] A randomised, double-blind, placebo-controlled trial of minocycline and/or omega-3 fatty acids added to treatment as usual for at-risk mental states (NAYAB): study protocol
    Qurashi, Inti
    Chaudhry, Imran B.
    Khoso, Ameer B.
    Farooque, Sana
    Lane, Steve
    Husain, Mohammad Omair
    Chu, Simon
    Sarginson, Jane
    Hamarani, Munir
    Naqvi, Haider A.
    Razzaque, Bushra
    Minhas, Fareed A.
    Yung, Alison R.
    Deakin, J. F. W.
    Husain, Nusrat
    TRIALS, 2017, 18
  • [3] A randomised, double-blind, placebo-controlled trial of minocycline and/or omega-3 fatty acids added to treatment as usual for at-risk mental states (NAYAB): study protocol
    Inti Qurashi
    Imran B. Chaudhry
    Ameer B. Khoso
    Sana Farooque
    Steve Lane
    Mohammad Omair Husain
    Simon Chu
    Jane Sarginson
    Munir Hamarani
    Haider A. Naqvi
    Bushra Razzaque
    Fareed A. Minhas
    Alison R. Yung
    J. F. W. Deakin
    Nusrat Husain
    Trials, 18
  • [4] Minocycline and/or omega-3 fatty acids added to treatment as usual for individuals with at risk mental states. A large multicenter double blind RCT
    Qurashi, I.
    Chaudhry, B., I
    Khoso, B. A.
    Husain, M. O.
    Hafeez, D.
    Kiran, T.
    Lane, S.
    Naqvi, A. H.
    Minhas, A. F.
    Nizami, T. A.
    Razzaque, B.
    Bokhari, Q. S.
    Yung, R. A.
    Deakin, B.
    Husain, N.
    JOURNAL OF PSYCHOSOMATIC RESEARCH, 2023, 169 : 2 - 2
  • [5] Omega-3 fatty acids as a treatment for perinatal depression: randomized double-blind placebo-controlled trial
    Rees, Anne-Marie
    Austin, Marie-Paule
    Parker, Gordon B.
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 2008, 42 (03): : 199 - 205
  • [6] A Double-Blind Placebo-Controlled Trial of Omega-3 Fatty Acids as a Monotherapy for Adolescent Depression
    Gabbay, Vilma
    Freed, Rachel D.
    Alonso, Carmen M.
    Senger, Stefanie
    Stadterman, Jill
    Davison, Beth A.
    Klein, Rachel G.
    JOURNAL OF CLINICAL PSYCHIATRY, 2018, 79 (04)
  • [7] A Double-Blind, Placebo-Controlled Trial of Omega-3 Fatty Acids in Tourette's Disorder
    Gabbay, Vilma
    Babb, James S.
    Klein, Rachel G.
    Panzer, Aviva M.
    Katz, Yisrael
    Alonso, Carmen M.
    Petkova, Eva
    Wang, Jing
    Coffey, Barbara J.
    PEDIATRICS, 2012, 129 (06) : E1493 - E1500
  • [8] Omega-3 fatty acids in major depressive disorder - A preliminary double-blind, placebo-controlled trial
    Su, KP
    Huang, SY
    Chiu, CC
    Shen, WW
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2003, 13 (04) : 267 - 271
  • [9] Omega 3 - Polyunsaturated fatty acids and migraine: A double-blind, placebo-controlled trial.
    Pradalier, A
    Bakouche, P
    Baudesson, G
    Delage, A
    Cornaille-Lafage, G
    Biason, P
    CEPHALALGIA, 1999, 19 (04) : 376 - 376
  • [10] Omega 3 fatty acids in bipolar disorder - A preliminary double-blind, placebo-controlled trial
    Stoll, AL
    Severus, WE
    Freeman, MP
    Rueter, S
    Zboyan, HA
    Diamond, E
    Cress, KK
    Marangell, LB
    ARCHIVES OF GENERAL PSYCHIATRY, 1999, 56 (05) : 407 - 412